|
|
Volumn 32, Issue 22, 2014, Pages 2389-2390
|
|
Onco-nephrology: An invitation to a new field
a b |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
VASCULOTROPIN INHIBITOR;
ACUTE KIDNEY FAILURE;
CANCER CENTER;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SURVIVAL;
CANCER THERAPY;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL (TOPIC);
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG CLEARANCE;
ELECTROLYTE DISTURBANCE;
GLOMERULONEPHRITIS;
GRAFT VERSUS HOST REACTION;
HUMAN;
HYPERTENSION;
KIDNEY DISEASE;
KIDNEY FUNCTION;
KIDNEY INJURY;
LETTER;
LIVER VENOOCCLUSIVE DISEASE;
MICROANGIOPATHY;
MULTICENTER STUDY (TOPIC);
MULTIPLE MYELOMA;
NEPHROLOGY;
ONCOLOGY;
OUTCOME ASSESSMENT;
PATIENT RISK;
PREVALENCE;
PRIORITY JOURNAL;
PROFESSIONAL KNOWLEDGE;
PROTEINURIA;
RISK ASSESSMENT;
RISK FACTOR;
STEM CELL TRANSPLANTATION;
SURVIVAL RATE;
TUMOR LYSIS SYNDROME;
HUMANS;
KIDNEY DISEASES;
MEDICAL ONCOLOGY;
NEOPLASMS;
NEPHROLOGY;
|
|
EID: 84905819860
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2014.56.5622 Document Type: Letter |
|
Times cited : (18)
|
|
References (9)
|
